| Literature DB >> 26456834 |
Hyeonwoo Kim1, Carlos Rodriguez-Navas1, Rahul K Kollipara2, Payal Kapur3, Ivan Pedrosa4, James Brugarolas5, Ralf Kittler2, Jin Ye6.
Abstract
Some cancer cells exhibit elevated levels of free fatty acids (FAs) as well as high levels of β-catenin, a transcriptional co-activator that promotes their growth. Here, we link these two phenomena by showing that unsaturated FAs inhibit degradation of β-catenin. Unsaturated FAs bind to the UAS domain of Fas-associated factor 1 (FAF1), a protein known to bind β-catenin, accelerating its degradation. FA binding disrupts the FAF1/β-catenin complex, preventing proteasomal degradation of ubiquitinated β-catenin. This mechanism for stabilization of β-catenin differs from that of Wnt signaling, which blocks ubiquitination of β-catenin. In clear cell renal cell carcinoma (ccRCC) cells, unsaturated FAs stimulated cell proliferation through stabilization of β-catenin. In tissues from biopsies of human ccRCC, elevated levels of unsaturated FAs correlated with increased levels of β-catenin. Thus, targeting FAF1 may be an effective approach to treat cancers that exhibit elevated FAs and β-catenin.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26456834 PMCID: PMC4618234 DOI: 10.1016/j.celrep.2015.09.010
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423